Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
xl019 | tyrosine-protein kinase jak2 | small molecule | NA | drugbank , DGIDB | Malignant Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Polycythemia Vera[MeSHID:D011087] |
1.16 | investigational | unknown |
xl019 | tyrosine-protein kinase jak2 | small molecule | NA | drugbank , DGIDB | Malignant Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Polycythemia Vera[MeSHID:D011087] |
1.16 | investigational | inhibitor |
xl019 | janus kinase 2 | NA | Successful target | TTD , DGIDB | Malignant Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Polycythemia Vera[MeSHID:D011087] |
1.16 | phase 3 | unknown |
xl019 | janus kinase 2 | NA | Successful target | TTD , DGIDB | Malignant Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Polycythemia Vera[MeSHID:D011087] |
1.16 | phase 3 | inhibitor |
click here to return to the previous page |